Financials in USD. Standardized financial statements.
A compact view of how Adverum Biotechnologies, Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.00M | $3.60M | $0 | $7.50M | $0 | $250,000 | $1.61M | $1.85M | $1.46M | $2.32M |
| Revenue Growth? | -72.2% | 0.0% | -100.0% | 0.0% | -100.0% | -84.5% | -12.8% | +27.1% | -37.3% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $4.16M | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $1.00M | $3.60M | $0 | $7.50M | -$4.16M | $0 | $0 | $0 | $0 | $2.32M |
| Gross Margin? | +100.0% | +100.0% | 0.0% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +100.0% |
| Operating Expenses? | $140.16M | $132.54M | $157.13M | $153.62M | $113.79M | $68.80M | $79.69M | $60.70M | $116.74M | $50.14M |
| Operating Income? | -$139.16M | -$128.94M | -$157.13M | -$146.12M | -$117.95M | -$68.55M | -$78.08M | -$58.85M | -$115.28M | -$47.82M |
| EBITDA? | -$135.51M | -$123.30M | -$150.61M | -$141.48M | -$112.23M | -$66.97M | -$71.33M | -$56.75M | -$52.97M | -$44.44M |
| Income Before Tax | -$130.93M | -$123.19M | -$154.46M | -$145.54M | -$116.39M | -$64.49M | -$73.88M | -$56.15M | -$114.52M | -$47.45M |
| Income Tax Expense | $0 | -$1.08M | $74,000 | $0 | $1.11M | $0 | -$1.25M | $0 | -$775,000 | $0 |
| Net Income? | -$130.93M | -$122.12M | -$154.54M | -$145.54M | -$117.51M | -$64.49M | -$72.63M | -$56.15M | -$113.75M | -$47.45M |
| EPS? | $-6.62 | $-2.02 | $-2.67 | $-1.48 | $-1.26 | $-0.87 | $-1.18 | $-1.29 | $-3.14 | $-1.86 |
| Diluted EPS? | $-6.62 | $-2.02 | $-2.67 | $-1.48 | $-1.26 | $-0.87 | $-1.18 | $-1.29 | $-3.14 | $-1.84 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality